GIS, NUS, And Novo Nordisk Team Up To Study Non-alcoholic Fatty Liver Disease In Asian Populations
New study will generate insights in the development and progression of the disease in Asia, which could support the development of effective diagnostics and therapies. The Agency for Science, Technology…
Share